CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 42 enrolled
Drug / intervention
Adherence Intervention +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01643473
NCT01643473N/ACompleted

Tailored Approaches to Improve Medication Adherence

NYU Langone Health·interventional·Posted Jul 18, 2012·Updated Sep 26, 2019

In Brief

A clinical study evaluating Adherence Intervention and Attention Control for Hypertension. Completed, enrolled 42 participants across 1 site.

Detailed Summary

The purpose of this study is to to culturally tailor a technology-based individualized adherence intervention for Black and Latino patients with uncontrolled HTN or T2DM, who are non-adherent to their medications, and determine its acceptability.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesUnited States

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJul 18, 2012
Enrollment StartApr 1, 2013
Primary CompletionFeb 20, 2018
Study CompletionMay 1, 2018
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 14.0 years ago

Interventions

Adherence Interventionbehavioral

Patients randomized to the TAI group will complete a tailoring survey at the baseline visit to identify the most salient adherence barriers to the individual, which will be used to create an individualized adherence profile. Following completion of the tailoring survey, patients will collaborate with the RA to identify the most suitable mix of intervention strategies for improving medication adherence (i.e., reminder aids, motivational interviewing, case management) that are matched to the barriers outlined on patients' individualized adherence profiles.

Attention Controlother

Health education videos on topics unrelated to medication adherence, hypertension or type 2 diabetes